PharmaFluidics Raises 2.7 Million Euros for Funding
PharmaFluidics has announced an additional 2.7 million Euros worth of funding to support its commercial launch and expand its analytical applications portfolio to biomarkers, diagnostics, and drug development.
Photo Credit: Vintage Tone/Shutterstock.com
PharmaFluidics has announced an additional 2.7 million Euros worth of funding to support its commercial launch and expand its analytical applications portfolio to biomarkers, diagnostics, and drug development.
Founded as a spin-off from the University of Brussels (VUB) in 2010 with a decade of top-level academic research as its foundation, PharmaFluidics aims to increase efficiency and resolution in liquid chromatography (LC) with ease of use and robustness, opening the way to further miniaturization and integration.
The company confirmed much of the funds will be used to speed up the commercialization of its range of microchipâbased chromatography cartridges. The cartridges are designed for use in biomarker, diagnostics, and
drug research and development applications across biotechnology and pharmaceutical industries. The remaining funds will be used to develop new application fields and reference cases, to broaden the market beyond the current pioneer users.
“These micro-chip columns have an immediate design and performance appeal to pioneer users in the pharmaceutical research and development segment,” said Johan Devenyns, Managing Director of PharmaFluidics. “We believe that ‘secondary features’ such as convenience of use, workflow simplification, column longevity and robustness, and reduced solvent consumption will allow for the future generations of microchip columns and cartridges to gain substantial market share. There is also a bright future for microchip-based columns to be used in combination with simplified, lower cost MS systems, which will become affordable in many more settings and places,” he added
PharmaFluidics also announced a presentation by Johan Devenyns at the “Knowledge for Growth” conference on 18 May 2017 in Ghent, Belgium.
The presentation will discuss micro-chip, pillar array columns, and monolithic chromatography separation beds and present examples of cell tryptic digests and plant tissue extracts to demonstrate the potential of the micro-chip technology. - L.B.
For more information on PharmaFluidics please visit: www.pharmafluidics.com
For more information on the “Knowledge for Growth” conference please visit: www.knowledgeforgrowth.be/en
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
